Worth a Look
Qualify for a free subscription to HealthLeaders magazine.
“Bandages” and “shrimp” are two words you don’t expect to hear in the same sentence. But for one Portland, OR-based company, they go together just fine.
HemCon Medical Technologies worked with the U.S. Army to develop a bandage made from chitosan, a naturally occurring, biocompatible substance derived from shrimp shells. The shells are processed, treated, formed into bandages and sterilized. The idea is that the chitosan attracts blood cells and seals a wound to allow the body to form a clot that stops hemorrhaging. And what if the patient has a shellfish allergy? HemCon says no known allergic reactions have occurred since the product launched in 2003.
Originally developed for use on the battlefield, the dressings are now used in acute-care settings through a distributorship agreement reached last fall with Dublin, OH-based Cardinal Health. Go to either www.hemcon.com or www.cardinalhealth.com to read more.
- NFP Hospitals' Revenue Growth at 'All-Time Low'
- CNO Leads $1M Charge for New Scrubs, Uniforms
- Transforming Cancer Care
- Acute Kidney Injury Gets New Focus
- Interventional Radiology No Longer a Sub-Specialty
- Sharp HealthCare Leaves Pioneer ACO Program
- Half of All Primary Care, Internal Medicine Jobs Unfilled in 2013
- mHealth Tackles Readmissions
- Proton Beam Therapy Poised for Growth in US
- MA an Insurance Proving Ground for Providers